Results 201 to 210 of about 571,937 (342)

Halorotetin B, A Novel Terpenoid Compound Derived from Marine Ascidian, Suppresses Tumor Growth by Targeting the Cell Cycle Regulator UBE2C

open access: yesAdvanced Science, EarlyView.
Halorotetin B, a novel small‐molecule terpenoid identified from an edible marine ascidian, exhibits strong anti‐tumor activity both in vitro and in vivo through direct targeting UBE2C to induce tumor cell cycle arrest and then lead tumor cell senescence. As a newly discovered UBE2C inhibitor, Halorotetin B can serve as a novel potential cell senescence
Shanhao Han   +6 more
wiley   +1 more source

Cat-scratch disease mimicking soft tissue sarcoma in a pediatric patient. [PDF]

open access: yesRadiol Case Rep
Castro D   +4 more
europepmc   +1 more source

Cat scratch disease without a history of cat exposure. [PDF]

open access: yesClin Case Rep, 2022
Oka K, Takagi Y, Hagiya H, Otsuka F.
europepmc   +1 more source

HEMAGGLUTINATING VIRUS ISOLATED FROM CAT SCRATCH DISEASE [PDF]

open access: bronze, 1960
W. Turner   +3 more
openalex   +1 more source

Neuroprotective Nanoplatform Integrating Antioxidant MXene Nanozymes and Ferroptosis Inhibitors for Targeted Therapy of Cerebral Ischemia‐Reperfusion Injury

open access: yesAdvanced Science, EarlyView.
Cerebral ischemia‐reperfusion injury (CIRI) is a key pathological process limiting the efficacy of stroke therapy. This study has developed an innovative, multifunctional, brain‐targeted nanoplatform (RFP) containing MXene nanoenzymes and ferroptosis inhibitors.
Lu Wang   +9 more
wiley   +1 more source

Cat scratch disease in children with nocturnal fever: A case report. [PDF]

open access: yesWorld J Clin Cases
Yin QL   +6 more
europepmc   +1 more source

Cat Scratch Disease of the Breast

open access: yesThe Breast Journal, 1999
Mary E., Lobrano   +3 more
openaire   +2 more sources

Alternative Pathway for Methyl Supply through the Coupling of SHMT1 and PEMT to Maintain Astrocytic Homeostasis in Parkinson's Disease

open access: yesAdvanced Science, EarlyView.
In Parkinson's disease, SHMT1 downregulation disrupts its interaction with PEMT in astrocytes, reducing SAM levels. This leads to H3K4me1 hypomethylation and decreased Slc1a2/Glul expression, ultimately exacerbating neuroexcitotoxicity and dopaminergic neuron loss.
Yue‐Han Chen   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy